Showing 661 - 680 results of 225,159 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 10 ((a decrease) OR (nn decrease)) ))', query time: 1.02s Refine Results
  1. 661

    Effects of increasing temperature and, CO<sub>2</sub> on quality of litter, shredders, and microorganisms in Amazonian aquatic systems by Renato Tavares Martins (4634317)

    Published 2017
    “…We hypothesized that simulated climate change (warming and elevated CO<sub>2</sub>) would: i) decrease leaf-litter quality, ii) decrease survival and leaf breakdown by shredders, and iii) increase microbial leaf breakdown and fungal biomass. …”
  2. 662
  3. 663
  4. 664
  5. 665

    CPGF NPs decrease the growth kinetics of breast cancer cells. by Kirtee D. Wani (636463)

    Published 2014
    “…<p>(<b>A</b>) The NPs decreased the number of cells in MDAMB231 and MCF7, indicated by cell growth assay. …”
  6. 666
  7. 667
  8. 668

    GSH, but not GSSG, specifically decreases ABCB10 ATP binding activity. by Wei Qiu (217045)

    Published 2015
    “…<p>A representative autoradiography image and the quantification shown in the bar graph demonstrate that GSH decreased [α-<sup>32</sup>P] 8-azido-ATP signal in ABCB10 from SMPs in a dose dependent manner, whereas GSSG did not. …”
  9. 669
  10. 670
  11. 671
  12. 672
  13. 673

    Decrease of NF-κB activity in tumor tissue of CCR5<sup>−/−</sup> mice. by Ju Kyoung Song (324058)

    Published 2013
    “…<p><b>A</b>, The DNA binding activity of NF-κB was determined in the nuclear extracts of the CCR5<sup>−/−</sup> mice and CCR5<sup>+/+</sup> mice tumor tissues by EMSA described in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0033747#s4" target="_blank">material and methods</a>. …”
  14. 674

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. We aimed to investigate the safety and efficacy of AZP-531 in patients with PWS for whom no approved treatment for hyperphagia is currently available.…”
  15. 675
  16. 676
  17. 677
  18. 678
  19. 679
  20. 680